Biopharmaceutical analytical testing services market size to increase by USD 3.44957 billion; North America to account for 33% of market growth - Technavio

News provided by

Feb 09, 2023, 18:00 ET

NEW YORK, Feb. 9, 2023 /PRNewswire/ -- The Biopharmaceutical Analytical Testing Services Market by Service, End-user, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 3.44957 billion between 2022 and 2027 at a CAGR of 12.61%. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report

Regional Analysis

Technavio has announced its latest market research report titled Global Biopharmaceutical Analytical Testing Services Market 2023-2027

By region, the global biopharmaceutical analytical testing services market is segmented into North America, APAC, Europe, South America, and Middle East and Africa. North America will account for 33% of market growth during the forecast period. Factors such as the presence of key vendors and high investments in the R&D of new drugs are driving the growth of the biopharmaceutical analytical testing services market in North America. Buy the report

Company Profiles

The biopharmaceutical analytical testing services market report includes information on the key products and recent developments of leading vendors, including:

Boston Analytical - The company offers biopharmaceutical analytical testing services such as dissolution testing, In-process, and lot release testing.
Catalent Inc. - The company offers biopharmaceutical analytical testing services such as GMP lot release testing.
Charles River Laboratories International Inc. - The company offers biopharmaceutical analytical testing services such as bioactivity and potency testing, contamination and impurity testing, and stability testing.
Coriolis Pharma Research GmbH - The company offers biopharmaceutical analytical testing services such as stability testing, and lot release testing.

Market Dynamics

The market is driven by factors such as the increase in demand for mAbs, an increase in the number of patent-expired drugs, and an increase in chronic diseases. However, the shortage of trained professionals is hindering market growth.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

By service, the market is segmented into bioanalytical, method development and validation, stability testing, and others. The bioanalytical segment accounted for the largest share of the market in 2022.
By geography, the market is segmented into North America, APAC, Europe, South America, and Middle East and Africa. North America held the largest share of the market in 2022.

Related Reports:

The bioprocess technology market size is expected to increase to USD 55.84 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.27%. The increase in infectious diseases is notably driving the bioprocess technology market growth, although factors such as the lack of trained laboratory professionals may impede the market growth.
The pharmaceutical glass tubing market size is expected to increase by USD 4.35 billion from 2021 to 2026, at a CAGR of 7.2%. The increasing strategic initiatives of market players is notably driving the pharmaceutical glass tubing market growth, although factors such as product recalls may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this biopharmaceutical analytical testing services market report?

CAGR of the market during the forecast period.
Detailed information on factors that will drive the growth of the market between 2023 and 2027
Precise estimation of the size of the biopharmaceutical analytical testing services market and its contribution to the parent market.
Accurate predictions about upcoming trends and changes in consumer behavior.
Growth of the market across North America, APAC, Europe, South America, and Middle East and Africa.
A thorough analysis of the market's competitive landscape and detailed information about vendors.
Comprehensive analysis of factors that will challenge the growth of biopharmaceutical analytical testing services market vendors.

Biopharmaceutical Analytical Testing Services Market Scope
Report Coverage	Details
Page number	171
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 12.61%
Market growth 2023-2027	USD 3449.57 million
Market structure	Fragmented
YoY growth 2022-2023(%)	11.67
Regional analysis	North America, APAC, Europe, South America, and Middle East and Africa
Performing market contribution	North America at 33%
Key countries	US, China, Japan, UK, and Germany
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc.
Market dynamics	Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Service
Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary – Chart on Incremental Growth
Exhibit 08: Executive Summary – Data Table on Incremental Growth
Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027

Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global biopharmaceutical analytical testing services market 2017 - 2021

Exhibit 18: Historic Market Size – Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)

4.2 Service Segment Analysis 2017 - 2021

Exhibit 19: Historic Market Size – Service Segment 2017 - 2021 ($ million)

4.3 End-user Segment Analysis 2017 - 2021

Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021

Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021

Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary

Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers

Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers

Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants

Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes

Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry

Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition

Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Service

6.1 Market segments

Exhibit 30: Chart on Service - Market share 2022-2027 (%)
Exhibit 31: Data Table on Service - Market share 2022-2027 (%)

6.2 Comparison by Service

Exhibit 32: Chart on Comparison by Service
Exhibit 33: Data Table on Comparison by Service

6.3 Bioanalytical - Market size and forecast 2022-2027

Exhibit 34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)

6.4 Method development and validation - Market size and forecast 2022-2027

Exhibit 38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)

6.5 Stability testing - Market size and forecast 2022-2027

Exhibit 42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)

6.6 Others - Market size and forecast 2022-2027

Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)

6.7 Market opportunity by Service

Exhibit 50: Market opportunity by Service ($ million)

7 Market Segmentation by End-user

7.1 Market segments

Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)

7.2 Comparison by End-user

Exhibit 53: Chart on Comparison by End-user
Exhibit 54: Data Table on Comparison by End-user

7.3 Pharma and biotech companies - Market size and forecast 2022-2027

Exhibit 55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)

7.4 CROs - Market size and forecast 2022-2027

Exhibit 59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on CROs - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on CROs - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by End-user

Exhibit 63: Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview

Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation

Exhibit 65: Chart on Market share by geography 2022-2027 (%)
Exhibit 66: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison

Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027

Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 APAC - Market size and forecast 2022-2027

Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)

9.5 Europe - Market size and forecast 2022-2027

Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.6 South America - Market size and forecast 2022-2027

Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%)

9.7 Middle East and Africa - Market size and forecast 2022-2027

Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)

9.8 US - Market size and forecast 2022-2027

Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

9.9 China - Market size and forecast 2022-2027

Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)

9.10 Japan - Market size and forecast 2022-2027

Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)

9.11 UK - Market size and forecast 2022-2027

Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.12 Germany - Market size and forecast 2022-2027

Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.13 Market opportunity by geography

Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges

Exhibit 110: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape

Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption

Exhibit 112: Overview on factors of disruption

11.4 Industry risks

Exhibit 113: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered

Exhibit 114: Vendors covered

12.2 Market positioning of vendors

Exhibit 115: Matrix on vendor position and classification

12.3 Almac Group Ltd.

Exhibit 116: Almac Group Ltd. - Overview
Exhibit 117: Almac Group Ltd. - Product / Service
Exhibit 118: Almac Group Ltd. - Key offerings

12.4 Boston Analytical

Exhibit 119: Boston Analytical - Overview
Exhibit 120: Boston Analytical - Product / Service
Exhibit 121: Boston Analytical - Key news
Exhibit 122: Boston Analytical - Key offerings

12.5 Catalent Inc.

Exhibit 123: Catalent Inc. - Overview
Exhibit 124: Catalent Inc. - Business segments
Exhibit 125: Catalent Inc. - Key news
Exhibit 126: Catalent Inc. - Key offerings
Exhibit 127: Catalent Inc. - Segment focus

12.6 Charles River Laboratories International Inc.

Exhibit 128: Charles River Laboratories International Inc. - Overview
Exhibit 129: Charles River Laboratories International Inc. - Business segments
Exhibit 130: Charles River Laboratories International Inc. - Key news
Exhibit 131: Charles River Laboratories International Inc. - Key offerings
Exhibit 132: Charles River Laboratories International Inc. - Segment focus

12.7 Coriolis Pharma Research GmbH

Exhibit 133: Coriolis Pharma Research GmbH - Overview
Exhibit 134: Coriolis Pharma Research GmbH - Product / Service
Exhibit 135: Coriolis Pharma Research GmbH - Key offerings

12.8 Element Materials Technology Group Ltd.

Exhibit 136: Element Materials Technology Group Ltd. - Overview
Exhibit 137: Element Materials Technology Group Ltd. - Product / Service
Exhibit 138: Element Materials Technology Group Ltd. - Key offerings

12.9 Eurofins Scientific SE

Exhibit 139: Eurofins Scientific SE - Overview
Exhibit 140: Eurofins Scientific SE - Business segments
Exhibit 141: Eurofins Scientific SE - Key news
Exhibit 142: Eurofins Scientific SE - Key offerings
Exhibit 143: Eurofins Scientific SE - Segment focus

12.10 ICON plc

Exhibit 144: ICON plc - Overview
Exhibit 145: ICON plc - Product / Service
Exhibit 146: ICON plc - Key offerings

12.11 Intertek Group Plc

Exhibit 147: Intertek Group Plc - Overview
Exhibit 148: Intertek Group Plc - Business segments
Exhibit 149: Intertek Group Plc - Key news
Exhibit 150: Intertek Group Plc - Key offerings
Exhibit 151: Intertek Group Plc - Segment focus

12.12 Merck KGaA

Exhibit 152: Merck KGaA - Overview
Exhibit 153: Merck KGaA - Business segments
Exhibit 154: Merck KGaA - Key news
Exhibit 155: Merck KGaA - Key offerings
Exhibit 156: Merck KGaA - Segment focus

12.13 Pace Analytical Services LLC

Exhibit 157: Pace Analytical Services LLC - Overview
Exhibit 158: Pace Analytical Services LLC - Product / Service
Exhibit 159: Pace Analytical Services LLC - Key offerings

12.14 SGS SA

Exhibit 160: SGS SA - Overview
Exhibit 161: SGS SA - Business segments
Exhibit 162: SGS SA - Key offerings
Exhibit 163: SGS SA - Segment focus

12.15 Solvias AG

Exhibit 164: Solvias AG - Overview
Exhibit 165: Solvias AG - Product / Service
Exhibit 166: Solvias AG - Key news
Exhibit 167: Solvias AG - Key offerings

12.16 STERIS Plc

Exhibit 168: STERIS Plc - Overview
Exhibit 169: STERIS Plc - Business segments
Exhibit 170: STERIS Plc - Key news
Exhibit 171: STERIS Plc - Key offerings
Exhibit 172: STERIS Plc - Segment focus

12.17 West Pharmaceutical Services Inc.

Exhibit 173: West Pharmaceutical Services Inc. - Overview
Exhibit 174: West Pharmaceutical Services Inc. - Business segments
Exhibit 175: West Pharmaceutical Services Inc. - Key news
Exhibit 176: West Pharmaceutical Services Inc. - Key offerings
Exhibit 177: West Pharmaceutical Services Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist

Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist

13.3 Currency conversion rates for US$

Exhibit 180: Currency conversion rates for US$

13.4 Research methodology

Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources

13.5 List of abbreviations

Exhibit 184: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio